RSS-Feed abonnieren
DOI: 10.1055/s-2006-956462
Rh-Catalyzed Sequential Hydroarylation/Hydrovinylation-Heterocyclization of β-(2-Aminophenyl)-α,β-ynones with Organoboron Derivatives: A New Approach to Functionalized Quinolines
Publikationsverlauf
Publikationsdatum:
23. November 2006 (online)
![](https://www.thieme-connect.de/media/synlett/200619/lookinside/thumbnails/10.1055-s-2006-956462-1.jpg)
Abstract
4-Aryl and 4-vinyl quinolines were prepared via a sequential procedure involving regioselective Rh(acac)(C2H2)/dppf-catalyzed hydroarylation/hydrovinylation of β-(2-aminophenyl)-α,β-ynones with arylboronic acids or potassium aryl and vinyl trifluoroborates, followed by nucleophilic attack of the amino group onto the carbonyl.
Key words
quinolines - hydroarylation - rhodium - alkynones - arylboronic acids
- 1
Bray PG.Ward SA.O’Neill PM. Curr. Top. Microbiol. 2005, 295: 3 -
2a
Zouhiri F.Danet M.Bérnard C.Normand-Bayle M.Mouscadet JF.Leh H.Thomas CM.Mbemba G.d’Angelo J.Desmaële D. Tetrahedron Lett. 2005, 46: 2201 -
2b
Normand-Bayle M.Bérnard C.Zouhiri F.Mouscadet JF.Leh H.Thomas CM.Mbemba G.Desmaële D.d’Angelo J. Bioorg. Med. Chem. Lett. 2005, 15: 4019 - 3
Narender P.Srinivas U.Ravinder M.Anada Rao B.Ramesh C.Harakishore K.Gangadasu B.Murthy USN.Jayathirtha Rao V. Bioorg. Med. Chem. 2006, 14: 4600 - 4
Rossiter S.Péron JM.Whitfield PJ.Jones K. Bioorg. Med. Chem. Lett. 2005, 15: 4806 - 5
Joshi AA.Viswanathan CL. Bioorg. Med. Chem. Lett. 2006, 16: 2613 - 6
Kiselyov AS.Piatnitsky E.Semenova M.Semenov VV. Bioorg. Med. Chem. Lett. 2006, 16: 602 - 7
Goodell JR.Puig-Basagoiti F.Forshey BM.Shi PY.Ferguson DM. J. Med. Chem. 2006, 49: 2127 - 8
Cappelli A.Pericot Mohr G.Gallelli A.Giuliani G.Anzini M.Vomero S.Fresta M.Porcu P.Maciocco E.Concas A.Biggio G.Donati A. J. Med. Chem. 2003, 46: 3568 - 9
Tong H.Wang L.Jing X.Wang F. Macromolecules 2003, 36: 2584 - 10
Tumambac GE.Rosencrance CM.Wolf C. Tetrahedron 2004, 60: 11293 - Selected references:
-
11a
Anguille S.Brunet JJ.Chu NC.Diallo O.Pages C.Vincendeau S. Organometallics 2006, 25: 2943 -
11b
Ichikawa J.Sakoda K.Moriyama H.Wada Y. Synthesis 2006, 1590 -
11c
Savitha G.Perumal PT. Tetrahedron Lett. 2006, 47: 3589 -
11d
Kouznestov VV.Bohorquez ARR.Saavedra LA.Medina RF. Mol. Diversity 2006, 10: 29 -
11e
Janza B.Studer A. Org. Lett. 2006, 8: 1875 -
11f
Jia CS.Wang GW. Lett. Org. Chem. 2006, 3: 289 -
11g
Lin XF.Cui SL.Wang YG. Tetrahedron Lett. 2006, 47: 3127 -
11h
Sivaprasad G.Rajesh R.Perumal PT. Tetrahedron Lett. 2006, 47: 1783 -
11i
Duggineni S.Sawant D.Saha B.Kundu B. Tetrahedron 2006, 62: 3228 -
11j
Chaudhuri MK.Hussain S. J. Chem. Sci. 2006, 118: 199 - 12
Arcadi A.Marinelli F.Rossi L.Verdecchia M. Synthesis 2006, 2019 - 13
Arcadi A.Marinelli F.Rossi E. Tetrahedron 1999, 55: 13233 - 14
Abbiati G.Arcadi A.Marinelli F.Rossi E. Eur. J. Org. Chem. 2003, 1423 - 15
Suzuki A. In Handbook of Organopalladium Chemistry for Organic Synthesis Vol. 1:Negishi E. Wiley; New York: 2002. p.249-262 - 16
Deng Y.Gong L.Mi A.Liu H.Jiang Y. Synthesis 2003, 337 - 17
Clark J.Macquarrie D. In Handbook of Green Chemistry and Technology Blackwell Science Ltd.; Oxford: 2002. - 18
Taniguchi M.Kobayashi S.Nakagawa M.Hino T.Kishi Y. Tetrahedron Lett. 1986, 27: 4763 -
19a
Arcadi A.Cacchi S.Fabrizi G.Marinelli F.Verdecchia M. Synlett 2006, 909 -
19b
Cacchi S.Fabrizi G. In Handbook of Organopalladium Chemistry for Organic Synthesis Vol. 1:Negishi E. Wiley; New York: 2002. p.1335-1359 - 20
Cacchi S.Fabrizi G.Marinelli F. Synlett 1999, 401 -
21a
Hayashi T.Inoue K.Taniguchi N.Ogasawara M. J. Am. Chem. Soc. 2001, 123: 9918 -
21b
Lautens M.Yoshida M. Org. Chem. 2002, 4: 123 -
21c
Lautens M.Yoshida M. J. Org. Chem. 2003, 68: 762 -
21d
Genin E.Michelet V.Genêt JP. Tetrahedron Lett. 2004, 45: 4157 -
21e
Genin E.Michelet V.Genêt JP. J. Organomet. Chem. 2004, 689: 3820 -
22a
Miura T.Sasaky T.Nakazawa H.Murakami M. J. Am. Chem. Soc. 2005, 127: 1390 -
22b
Miura T.Shimada M.Murakami M. Synlett 2005, 667 -
22c
Miura T.Murakami M. Org. Lett. 2005, 7: 3340 -
22d
Shitani R.Okamoto K.Hayashi T. Chem. Lett. 2005, 34: 1294 -
22e
Matsuda T.Makino M.Murakami M. Chem. Lett. 2005, 34: 1416 -
22f
Miura T.Shimada M.Murakami M. J. Am. Chem. Soc. 2005, 127: 1094 -
22g
Shintani R.Okamoto K.Otomaru Y.Ueyama K.Hayashi T. J. Am. Chem. Soc. 2005, 127: 54 -
25a
Darses S.Genêt JP. Eur. J. Org. Chem. 2003, 4313 -
25b
Molander GA.Figueroa R. Aldrichimica Acta 2005, 38: 49 -
26a
Ueda M.Miyaura N. J. Org. Chem. 2000, 65: 4450 -
26b
Pucheault M.Darses S.Genêt JP. J. Am. Chem. Soc. 2004, 126: 15356 -
27a
Matsuda T.Makino M.Murakami M. Org. Lett. 2004, 6: 1257 -
27b
Takezawa A.Yamaguchi K.Toshimichi O.Yamamoto Y. Synlett 2002, 1733
References and Notes
Typical Procedure: To a mixture of 1c (0.106 g, 0.40 mmol), phenylboronic acid (0.244 g, 2 mmol), Rh(acac)(C2H4)2 (0.0035 g, 0.014 mmol) and dppf (0.015 g, 0.027 mmol) in a screw-capped Pyrex tube were added dioxane (1 mL) and H2O (0.1 mL). The tube was purged with N2, closed and the mixture was stirred at 100 °C for 4.5 h. After cooling, the mixture was purified by column chromatography (silica gel; hexane-EtOAc, 97:3) to give 4g (0.106 g, 82% yield); mp 116-117 °C. IR (KBr): 1690, 1610, 1600 cm-1. 1H NMR (CDCl3): δ = 8.29 (d, J = 8.5 Hz, 2 H), 8.26-8.22 (m, 1 H), 8.09 (d, J = 8.5 Hz, 2 H), 7.91 (d, J = 8.4 Hz, 2 H), 7.83 (s, 1 H, C3-H), 7.78-7.70 (m, 1 H), 7.54-7.45 (m, 6 H), 2.65 (s, 3 H). 13C NMR (CDCl3): δ = 197.8, 155.4, 149.5, 148.8, 143.8, 138.2, 137.4, 130.2, 129.8, 129.5, 128.8, 128.6, 128.5, 127.7, 126.9, 126.0, 125.7, 119.2, 26.8. MS (EI): m/z (%) = 323 (100) [M+], 309 (8), 281 (20).
24
Characterization of other quinoline derivatives.
Compound 4a: oil. IR (neat): 1610, 1590, 1550 cm-1. 1H NMR (CDCl3): δ = 8.22 (d, J = 8.3 Hz, 1 H), 7.95 (d, J = 7.9 Hz, 1 H), 7.76-7.68 (m, 1 H), 7.55-7.44 (m, 8 H), 7.14 (s, 1 H), 7.17-7.10 (m, 1 H), 2.45 (s, 3 H), 2.38 (s, 3 H). 13C NMR (CDCl3): δ = 159.8, 148.4, 148.3, 138.3, 138.2, 137.8, 135.9, 131.7, 130.0, 129.8, 129.6, 129.4, 128.6, 128.3, 126.7, 126.3, 125.6, 125.1, 122.6, 21.2, 20.4. MS (EI): m/z (%) = 309 (100) [M+].
Compound 4b: oil. IR (neat): 1610, 1590, 1550 cm-1. 1H NMR (CDCl3): δ = 8.22 (d, J = 8.4 Hz, 1 H), 7.89 (d, J = 8.3 Hz, 1 H), 7.76-7.68 (m, 1 H), 7.54-7.42 (m, 5 H), 7.24-7.09 (m, 3 H), 7.13 (s, 1 H), 2.44 (s, 3 H), 2.37 (s, 3 H). 13C NMR (CDCl3): δ = 162.9 (d, J = 248.0 Hz, C-F), 159.9, 148.5, 147.2, 138.4, 137.7, 135.9, 134.2 (d, J = 3.2 Hz), 131.7, 131.4, 131.2, 130.1, 129.8, 129.5, 126.8, 126.5, 125.3, 122.7, 115.7 (d, J = 21.5 Hz), 21.2, 20.4. MS (EI): m/z (%) = 327 (100) [M+].
Compound 4c: oil. IR (neat): 1600, 1590, 1550 cm-1.1H NMR (CDCl3): δ = 8.24 (d, J = 8.3 Hz, 1 H), 7.98 (d, J = 8.4 Hz, 1 H), 7.74-7.66 (m, 1 H), 7.48-7.42 (m, 5 H), 7.30 (d, J = 7.9 Hz, 2 H), 7.13 (s, 1 H), 7.17-7.09 (s, 1 H), 2.45 (s, 3 H), 2.43 (s, 3 H), 2.37 (s, 3 H). 13C NMR (CDCl3): δ = 159.8, 148.4, 148.3, 138.2, 137.8, 135.8, 135.2, 131.6, 129.9, 129.8, 129.5, 129.3, 128.7, 126.7, 126.2, 125.6, 125.3, 122.6, 21.3, 21.2, 20.4. MS (EI): m/z (%) = 323 (100) [M+].
Compound 4d: oil. IR (neat): 1610, 1600, 1550 cm-1. 1H NMR (CDCl3): δ = 8.20 (d, J = 8.5 Hz, 1 H), 8.14 (d, J = 8.8 Hz, 2 H), 7.85 (d, J = 8.3 Hz, 1 H), 7.74 (s, 1 H), 7.71-7.63 (m, 1 H), 7.53-7.50 (m, 5 H), 7.43-7.35 (m, 1 H), 7.01 (d, J = 8.8 Hz, 2 H), 3.83 (s, 3 H). 13C NMR (CDCl3): δ = 160.8, 156.4, 148.9, 148.8, 138.5, 132.1, 129.9, 129.5, 129.4, 128.9, 128.5, 128.3, 125.9, 125.6, 125.5, 118.8, 114.2, 55.3. MS (EI): m/z (%) = 311 (100) [M+].
Compound 4e: mp 118-120 °C. IR (KBr): 1600, 1550 cm-1. 1H NMR (CDCl3): δ = 8.21-8.10 (m, 1 H), 8.15 (d, J = 8.8 Hz, 2 H), 7.84 (d, J = 8.4 Hz, 1 H), 7.74 (s, 1 H), 7.72-7.65 (m, 1 H), 7.43 (d, J = 8.0 Hz, 2 H), 7.44-7.35 (m, 1 H), 7.32 (d, J = 8.0 Hz, 2 H), 7.01 (d, J = 8.8 Hz, 2 H), 3.84 (s, 1 H), 2.45 (s, 1 H). 13C NMR (CDCl3): δ = 160.9, 156.5, 149.1, 148.9, 138.2, 135.7, 132.4, 129.9, 129.5, 129.34, 129.27, 128.9, 127.4, 125.8, 125.7, 118.8, 114.2, 55.4, 21.3. MS (EI): m/z (%) = 325 (100) [M+].
Compound 4f: mp 120-121 °C. IR (KBr): 1620, 1600, 1550 cm-1. 1H NMR (CDCl3): δ = 8.17-8.10 (m, 4 H), 7.97 (s, 1 H), 7.79 (d, J = 16.1 Hz, 1 H), 7.72-7.59 (m, 3 H), 7.52-7.30 (m, 5 H), 7.04 (d, J = 8.8 Hz, 2 H), 3.86 (s, 3 H). 13C NMR (CDCl3): δ = 160.7, 156.8, 148.8, 143.5, 136.8, 134.8, 132.5, 130.2, 129.4, 128.9, 128.7, 127.1, 125.9, 123.7, 123.3, 114.7, 114.2, 55.4. MS (EI): m/z (%) = 337 (100) [M+].
Compound 4h: mp 89-90 °C. IR (KBr): 1680, 1610, 1590 cm-1. 1H NMR (CDCl3): δ = 8.25-8.23 (m, 1 H), 8.27 (d, J = 8.5 Hz, 2 H), 8.08 (d, J = 8.5 Hz, 2 H), 8.10-8.05 (m, 1 H), 7.87 (s, 1 H), 7.94-7.17 (m, 1 H), 7.60-7.50 (m, 3 H), 7.40-7.35 (m, 1 H), 2.65 (s, 3 H). 13C NMR (CDCl3): δ = 197.8, 155.5, 148.5, 144.5, 143.4, 138.5, 137.4, 130.2, 129.9, 128.9, 127.7, 127.0, 126.5, 125.6, 125.1, 119.1, 26.7. MS (EI): m/z (%) = 329 (71) [M+], 314 (100), 286 (41).
Compound 4i: mp 112-113 °C. IR (KBr): 1600, 1560 cm-1. 1H NMR (CDCl3): δ = 8.30 (d, J = 8.6 Hz, 1 H), 8.26-8.20 (m, 1 H), 8.01 (d, J = 8.4 Hz, 1 H), 7.96-7.90 (m, 2 H), 7.81-7.72 (m, 2 H), 7.67 (s, 1 H), 7.61-7.47 (m, 9 H). 13C NMR (CDCl3): δ = 159.0, 148.7, 138.7, 138.1, 134.0, 131.3, 130.1, 129.6, 129.1, 128.6, 128.5, 128.4, 127.8, 126.6, 125.9, 125.7, 125.5, 125.4, 123.4. MS (EI): m/z (%) = 331 (100) [M+], 255 (40).
Compound 4j: mp 82-83 °C. IR (KBr): 1600, 1560 cm-1. 1H NMR (CDCl3): δ = 8.49 (s, 1 H), 8.37 (d, J = 7.5 Hz, 1 H), 8.25 (d, J = 8.6 Hz, 1 H), 7.91 (d, J = 8.5 Hz, 1 H), 7.80 (s, 1 H), 7.80-7.60 (m, 3 H), 7.55-7.44 (m, 6 H). 13C NMR (CDCl3): δ = 155.1, 149.7, 148.9, 140.4, 138.2, 130.8, 130.3, 129.8, 129.6, 129.3, 128.7, 128.6, 126.8, 125.9 (q, J = 3.6 Hz), 125.7, 124.4 (q, J = 3.7 Hz), 118.9, 29.7. MS (EI): m/z (%) = 349 (100) [M+].
Compound 4k: mp 75-77 °C. IR (KBr): 1600, 1570, 1550 cm-1. 1H NMR (CDCl3): δ = 8.48-8.33 (m, 3 H), 8.19 (d, J = 8.4 Hz, 1 H), 8.06 (s, 1 H), 7.76-7.55 (m, 5 H), 7.01 (d, J = 3.3 Hz, 1 H), 6.63 (m, 1 H). 13C NMR (CDCl3): δ = 155.2, 151.0, 149.2, 144.1, 140.2, 136.9, 130.7, 130.5, 129.8, 129.3, 127.2, 125.9 (q, J = 3.6 Hz), 125.2, 124.4 (q, J = 3.7 Hz), 123.7, 116.1, 112.4, 112.1. MS (EI): m/z (%) = 339 (100) [M+].
Compound 4l: mp 125-127 °C. IR (KBr): 1610, 1590, 1570 cm-1. 1H NMR (CDCl3): δ = 7.96 (s, 1 H), 7.97-7.91 (m, 1 H), 7.56-7.49 (m, 5 H), 7.46-7.10 (m, 4 H), 7.01 (d, J = 8.2 Hz, 1 H), 3.85 (s, 3 H). 13C NMR (CDCl3): δ = 159.6 (dd, J
1
= 247.1 Hz, J
2
= 12.0 Hz), 158.8 (dd, J
1
= 259.9 Hz, J
2
= 13.4 Hz), 157.3, 156.1, 146.8 (dd, J
1
= 3.2 Hz, J
2
= 5.4 Hz), 137.8, 131.8, 130.7, 129.4, 129.0, 128.8, 128.6, 125.4, 121.4, 111.3, 105.2-104.2 (two overlapping multiplets), 55.7. MS (EI): m/z (%) = 347 (100) [M+], 316 (51).
Compound 4m: mp 88-90 °C. IR (KBr): 1790, 1590, 1550 cm-1. 1H NMR (CDCl3): δ = 8.15-8.06 (m, 3 H), 7.74-7.60 (m, 4 H), 7.52 (s, 1 H), 7.46-7.42 (m, 1 H), 6.81 (t, J = 2.6 Hz, 1 H), 3.05-2.95 (m, 1 H), 2.66 (s, 3 H), 2.60-2.25 (m, 2 H), 2.10-1.90 (m, 2 H), 1.45-1.35 (m, 2 H), 0.94 (s, 9 H). 13C NMR (CDCl3): δ = 197.5, 158.4, 148.4, 147.0, 139.2, 137.6, 134.0, 133.0, 130.9, 130.1, 129.3, 128.8, 128.5, 128.3, 128.1, 126.0, 125.0, 118.3, 43.9, 32.2, 27.9, 27.5, 27.2, 26.7, 24.3. MS (EI): m/z (%) = 384 (100) [M+], 327 (40).
Compound 4n: mp 117-119 °C. IR (KBr): 1590, 1550, 1510 cm-1. 1H NMR (CDCl3): δ = 8.13-8.06 (m, 2 H), 7.78 (d, J = 15.9 Hz, 1 H), 7.74 (s, 1 H), 7.70-7.56 (m, 3 H), 7.51-7.26 (m, 4 H), 7.30 (d, J = 15.9 Hz, 1 H), 6.81 (t, J = 2.6 Hz, 1 H), 3.05-2.92 (m, 1 H), 2.65-2.30 (m, 2 H), 2.20-2.00 (m, 2 H), 1.50-1.35 (m, 2 H), 0.94 (s, 9 H). 13C NMR (CDCl3): δ = 158.9, 148.4, 142.7, 137.8, 136.9, 134.5, 130.4, 130.2, 129.1, 128.9, 128.6, 127.1, 125.7, 125.4, 123.9, 123.2, 114.2, 44.0, 32.3, 27.9, 27.7, 27.3, 23.3. MS (EI): m/z (%) = 368 (50) [M+], 353 (15), 311 (100).